Phoenix Biotech Acquisition Financials
PBAXUDelisted Stock | USD 10.87 0.00 0.00% |
Phoenix |
Please note, the imprecision that can be found in Phoenix Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Phoenix Biotech Acquisition. Check Phoenix Biotech's Beneish M Score to see the likelihood of Phoenix Biotech's management manipulating its earnings.
Phoenix Biotech Stock Summary
Phoenix Biotech Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in Oakland, California. Phoenix Biotech is traded on NASDAQ Exchange in the United States.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US71902K2042 |
Business Address | 2201 Broadway, Oakland, |
Sector | Capital Markets |
Industry | Financials |
Benchmark | Dow Jones Industrial |
Website | www.phoenixbiotechacquisitioncorp.com |
Phone | 215 731 9450 |
Currency | USD - US Dollar |
Phoenix Biotech Key Financial Ratios
Return On Asset | -0.0255 | |||
Number Of Shares Shorted | 86 | |||
Beta | 0.044 | |||
Z Score | -0.03 |
Phoenix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Phoenix Biotech's current stock value. Our valuation model uses many indicators to compare Phoenix Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phoenix Biotech competition to find correlations between indicators driving Phoenix Biotech's intrinsic value. More Info.Phoenix Biotech Acquisition is regarded fourth in return on asset category among its peers. It is regarded fifth in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Phoenix Biotech by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Phoenix Biotech Market Pulse
Quote | 10.87 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 10.87 |
Low | 10.87 |
High | 10.87 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Phoenix Biotech is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Phoenix has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Phoenix Biotech's financials are consistent with your investment objective using the following steps:- Review Phoenix Biotech's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Phoenix Biotech's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Phoenix Biotech's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Phoenix Biotech's stock is overvalued or undervalued.
Phoenix Biotech December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Phoenix Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phoenix Biotech Acquisition. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phoenix Biotech Acquisition based on widely used predictive technical indicators. In general, we focus on analyzing Phoenix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phoenix Biotech's daily price indicators and compare them against related drivers.
Information Ratio | 0.003 | |||
Maximum Drawdown | 21.82 | |||
Value At Risk | (0.28) | |||
Potential Upside | 0.6512 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Phoenix Stock
If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data |